Providing innovative and actionable brand insights through behavioral economics-based methodologies.

Design and execute custom primary research among HCPs, patients and ancillary audiences with expertise in landscape assessments, driver analysis, segmentation, concept testing, ATUs/tracking, and patient chart studies. Proficiency in immunology, ophthalmology and neurology.

-Direct gastroenterology syndicated studies focused on Crohn's disease and ulcerative colitis.-Survey writing-Data analysis-Report writing-Client management

Overall-Research design and execution collaboration with all levels of client organizations from analyst to vice-presidents/CEOs.-Secondary data source (Rx data, competitive intelligence) knowledge for strategic planning and research design/execution.-Co-developed and co-managed a full service, primary research organization.Pre-launch-Planned and executed pre-launch market research plans in 7 separate treatment areas over the past 5 years (diabetic macular edema, molecular diagnostics, moderate-severe acute pain, life-threatening allergy, chronic kidney disease, osteoarthritis pain, advanced melanoma).-Designed and executed quantitative market landscape and positioning research that lead to 400% increase in sales for molecular diagnostic platform within 18 months of launch in the US market (worth at least $4 million in platform revenue).-Designed and executed market landscape and messaging research for first of its kind metabolic acidosis therapy with $2 billion in potential US revenues by 2021.Post-launch-Planned and executed post-launch market research plans in 10 separate treatment areas in the past 5 years (diabetic macular edema, moderate-severe acute pain, chronic pain, osteoarthritis, life-threatening allergy, opioid addiction, influenza, molecular diagnostics).-Designed and executed ATU tracker program that measured continuous patient share improvement across 4 neurologic indications for an injectable neuromodulator (worth at least $6 million in revenue among targets per wave).-In 2017 and 2018, designed and executed US HCP & Consumer ATU tracker program that measured 35% improvement in market share for a life-threatening allergy injectable (worth at least $25 million in US revenue). Audience Types Researched in the Past 5 Years-23 different types of health care professional/specialties studies-7 different diagnoses patient/caregiver studies-4 different types of payer/decision-maker studies.

Conducted new product/indication assessments for input into forecasts for over two dozen therapies and medical devices.Increased revenue and business development opportunities with creation of new seminar, Primary Marketing Research for Forecasting, which sold out inaugural session.

Design pre-launch program for SUSTIVA (efavirenz) prior to FDA approval delay.

Designed, managed and executed quantitative marketing research and consulting engagements for pharma/biopharm/medical device companies.

Initially managed primary research projects and data analysis for biopharmaceutical products including hemophilia therapy, NovoSeven, and growtrh hormone therapy, Norditropin. Responsibilities expanded to include providing direction to primary marketing research projects and data analysis for diabetes therapy portfolio as well.